HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
COB protocol (BOP protocol)
chemotherapy protocol consisting of above compounds; used in the treatment of ovarian tumors
Also Known As:
BOP protocol
; PBV regimen; VBP protocol
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Therapy Context: Research Results
Therapeutics: 1158551
Drug Therapy: 293145
Combination Drug Therapy: 12066
Antineoplastic Combined Chemotherapy Protocols: 35
COB protocol: 1
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
COB protocol: 1
Clinical Protocols
Antineoplastic Protocols: 55
Antineoplastic Combined Chemotherapy Protocols: 35
COB protocol: 1
Carbohydrates: 22023
Glycoconjugates: 1353
Glycopeptides: 1928
Bleomycin: 9833
COB protocol: 1
Amino Acids, Peptides, and Proteins: 1
Peptides: 82426
Glycopeptides: 1928
Bleomycin: 9833
COB protocol: 1
Inorganic Chemicals: 9
Platinum Compounds: 758
Cisplatin: 46373
COB protocol: 1
Nitrogen Compounds: 67
Cisplatin: 46373
COB protocol: 1
Chlorine Compounds: 8
Cisplatin: 46373
COB protocol: 1
Heterocyclic Compounds: 198
Alkaloids: 5398
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
COB protocol: 1
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Indoles: 200
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
COB protocol: 1
Indolizines: 3
Indolizidines: 2
Indole Alkaloids: 200
Secologanin Tryptamine Alkaloids: 81
Vinca Alkaloids: 463
Vincristine: 9251
COB protocol: 1
Experts
1.
Blumenstengel, K
: 1 article (02/2001)
2.
Fricke, H J
: 1 article (02/2001)
3.
Höffken, K
: 1 article (02/2001)
4.
Kath, R
: 1 article (02/2001)
5.
Peters, H D
: 1 article (02/2001)
Related Diseases
1.
Leukopenia
02/23/2001 - "
Predominant features of side effects of the BOP protocol were myelotoxicity of WHO grade III/IV in 8 of 109 cycles leukopenia (8%), thrombocytopenia 3 cyles (3%) and anaemia in 4 cycles (4%).
"
2.
Thrombocytopenia 3
02/23/2001 - "
Predominant features of side effects of the BOP protocol were myelotoxicity of WHO grade III/IV in 8 of 109 cycles leukopenia (8%), thrombocytopenia 3 cyles (3%) and anaemia in 4 cycles (4%).
"